This funding opportunity supports pharmacodynamic, pharmacokinetic, and in vivo efficacy studies of therapeutic agents including small molecules and biologics targeting neurological or neuromuscular disorders. The goal is to advance projects to meet criteria for further translational development programs. Clinical trials are not allowed under this FOA.
Eligible applicants include Native American tribal organizations, state and local governments, small businesses, nonprofits, institutions of higher education, and public housing authorities. See additional information for full eligibility details.
